tiprankstipranks
Trending News
More News >

Immix Biopharma Enters At The Market Offering Agreement

Story Highlights
Immix Biopharma Enters At The Market Offering Agreement

Don’t Miss TipRanks’ Half-Year Sale

The latest announcement is out from Immix Biopharma ( (IMMX) ).

On June 3, 2025, Immix Biopharma, Inc. entered into an At The Market Offering Agreement with Citizens JMP Securities, LLC to offer and sell shares of its common stock at its discretion. This agreement allows the company to raise capital through the sale of shares, with the agent receiving a 3% commission on sales, potentially impacting the company’s financial flexibility and market operations.

The most recent analyst rating on (IMMX) stock is a Buy with a $7.00 price target. To see the full list of analyst forecasts on Immix Biopharma stock, see the IMMX Stock Forecast page.

More about Immix Biopharma

Average Trading Volume: 155,164

Technical Sentiment Signal: Buy

Current Market Cap: $72.48M

For detailed information about IMMX stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1